Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic

Xiaoming Liu1, Yao Zou1, Yingchi Zhang1

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Division of Pediatric Blood Diseases Center, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.

BMC Cancer
|November 9, 2021
PubMed

Insights

Chemotherapy for acute lymphoblastic leukemia (ALL) can cause infections. This study found gut microbiota changes are linked to pneumonia in pediatric ALL patients, suggesting new personalized care approaches.

Area of Science:

  • Microbiome research
  • Pediatric oncology
  • Infectious disease

Background:

  • Children with acute lymphoblastic leukemia (ALL) undergoing chemotherapy face a high risk of infection.
  • Gut microbiota disturbances are implicated in impaired intestinal barrier function, bacterial infections, and inflammation.

Purpose of the Study:

  • To investigate gut microbiota alterations in pediatric ALL patients.
  • To assess the relationship between gut microbiota changes and chemotherapy-induced pneumonia.

Main Methods:

  • A case-control study involving 14 pneumonia cases and 44 controls.
  • Characterization of physiological parameters and gut microbiota using microarray-based techniques.

Main Results:

  • Significant differences in gut microbial alpha and beta diversity were observed between groups.
  • Specific bacteria (Enterococcus malodoratus, Ochrobactrum anthropi, Actinomyces cardiffensis) were more abundant in pneumonia cases.
  • Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, including bacterial secretion systems, were enriched in the pneumonia group.

Conclusions:

  • Gut microbiota alterations are associated with chemotherapy-induced pneumonia in pediatric ALL.
  • These findings offer new insights for personalized clinical care in pediatric ALL management.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
389
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
932
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
84.1K